Emerge Weight Loss Tirzepatide Cost: Dose-Tiered Plans Compared

Last reviewed: September 13, 2026 Last updated: September 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Emerge Weight Loss prices compounded tirzepatide injections by dose: $224/month at 2.5 mg, $239 at 5 mg, $249 at 7.5 mg, $269 at 10 mg, $279 at 12.5 mg, and $289 at 15 mg (the latter two available to existing patients only; emergeweight.com/pricing, captured September 4, 2026). An oral dissolving tablet option starts at $149/month, and a maintenance program costs $148/month ($49 supervision plus $99 medication). PlexusDx charges $289/month month-to-month for tirzepatide injection at any dose, $269/month on a three-month commitment, and $249/month on a six-month commitment. Emerge holds a price advantage at starter and mid-range doses with no commitment required; PlexusDx becomes competitive at higher doses and for patients who prefer billing simplicity as they titrate. No signup, doctor, shipping, or membership fees appear on either platform for standard tirzepatide plans.

At-a-glance comparison

Emerge pricing captured September 4, 2026 from emergeweight.com/pricing; PlexusDx pricing captured September 13, 2026.

Emerge tirzepatide injection pricing by dose

Emerge Weight Loss structures its compounded tirzepatide injection pricing around six dose tiers, each billed monthly for a four-week supply. The tiering reflects the quantity of active pharmaceutical ingredient per dose:

• 2.5 mg: $224/month
• 5 mg: $239/month
• 7.5 mg: $249/month
• 10 mg: $269/month
• 12.5 mg: $279/month (existing patients only)
• 15 mg: $289/month (existing patients only)

The 12.5 mg and 15 mg tiers are restricted to existing patients; new enrollees begin at 2.5 mg or lower doses and titrate upward under clinician guidance. All prices are all-inclusive: no signup fee, no doctor fee, no shipping charge, and no membership fee for standard tirzepatide plans (emergeweight.com/pricing, captured September 4, 2026).

PlexusDx tirzepatide injection pricing

PlexusDx charges a single rate for compounded tirzepatide injection regardless of dose, with discounts tied to commitment length:

• Month-to-month: $289/month
• Three-month commitment: $269/month
• Six-month commitment: $249/month

A patient starting at 2.5 mg and escalating to 10 mg or 15 mg pays the same monthly rate throughout treatment. No membership fee, no separate visit or shipping charges (plexusdx.com/products/tirzepatide-injection, captured September 13, 2026).

Like-for-like monthly and 12-month cost comparison

Because Emerge uses dose-tiered pricing and PlexusDx uses commitment-tiered pricing, the most useful comparisons pair Emerge doses against PlexusDx commitment levels that produce matching or near-matching monthly rates. All 12-month totals below are our calculation (monthly rate × 12).

Emerge 2.5 mg ($224/month) vs PlexusDx

• Emerge 2.5 mg: $224/month, $2,688/year, month-to-month
• PlexusDx six-month ($249): $249/month, $2,988/year—$300 more annually
• PlexusDx month-to-month ($289): $289/month, $3,468/year—$780 more annually

Verdict: Emerge holds a $65–$300/year advantage over PlexusDx at the starting dose, with no commitment required.

Emerge 7.5 mg ($249/month) vs PlexusDx six-month ($249/month)

• Emerge 7.5 mg: $249/month, $2,988/year, month-to-month
• PlexusDx six-month: $249/month, $2,988/year, requires six-month commitment

Verdict: Identical monthly and annual cost. Emerge offers month-to-month flexibility at the same price PlexusDx charges with a six-month commitment.

Emerge 10 mg ($269/month) vs PlexusDx three-month ($269/month)

• Emerge 10 mg: $269/month, $3,228/year, month-to-month
• PlexusDx three-month: $269/month, $3,228/year, requires three-month commitment

Verdict: Identical monthly and annual cost. Emerge offers month-to-month flexibility at the same price PlexusDx charges with a three-month commitment.

Emerge 15 mg ($289/month, existing patients) vs PlexusDx month-to-month ($289/month)

• Emerge 15 mg: $289/month, $3,468/year, month-to-month, existing patients only
• PlexusDx month-to-month: $289/month, $3,468/year, any dose, no restriction

Verdict: Identical monthly and annual cost. PlexusDx offers the same $289 rate to new patients at any dose; Emerge restricts the 15 mg tier to existing patients.

Oral tirzepatide and maintenance options

Emerge offers an oral dissolving tablet (ODT) formulation of compounded tirzepatide at $149/month for a one-month supply (emergeweight.com/pricing, captured September 4, 2026). A maintenance program—$148/month total, broken into $49 for supervision and $99 for a medication vial—is also available for patients who have reached goal weight and seek a lower-cost continuation option.

PlexusDx offers tirzepatide oral capsules at $349/month month-to-month, $299/month on a three-month commitment, and $279/month on a six-month commitment. A microdose GLP-1 injection protocol designed for maintenance costs $129/month month-to-month.

Emerge's oral and maintenance options carry lower monthly costs than PlexusDx counterpart offerings; PlexusDx oral capsules are formulated for patients who prefer capsules over dissolving tablets, and the microdose protocol targets patients seeking the lowest effective maintenance dose.

Fee structure and inclusions

Emerge Weight Loss advertises no signup fee, no doctor fee, no shipping fee, and no membership fee for standard tirzepatide plans. The advertised monthly price covers medication, provider access, and shipping (emergeweight.com/pricing, captured September 4, 2026).

PlexusDx similarly bundles the online provider visit, prescription, compounded medication, and shipping into the advertised monthly price with no separate fees or membership charges (plexusdx.com/products/tirzepatide-injection, captured September 13, 2026).

Both platforms deliver four-week or one-month supplies and bill monthly. Neither platform charges separately for clinician consultations, dose adjustments, or follow-up messaging within the scope of standard care.

Decision factors: dose trajectory vs billing certainty

The choice between Emerge's dose-tiered model and PlexusDx's dose-stable model hinges on your expected treatment path and tolerance for changing monthly bills.

Emerge's advantage: lower cost at starter and mid-range doses with month-to-month flexibility

Patients who anticipate starting at 2.5 mg or 5 mg and stabilizing at a mid-range dose (7.5 mg or 10 mg) pay less per month with Emerge—often $20 to $65 less than PlexusDx month-to-month, with no commitment required. For a patient who spends six months at 5 mg and six months at 7.5 mg, Emerge's cost over 12 months is $2,868 (our calculation: [$239 × 6] + [$249 × 6]), compared to PlexusDx month-to-month at $3,468—a $600 annual difference.

PlexusDx's advantage: predictable billing through titration and higher doses

Patients who expect to titrate to higher doses (12.5 mg or 15 mg) or who prefer knowing their monthly cost will not change as their dose increases may favor PlexusDx. A patient who moves from 2.5 mg to 15 mg over six months pays $289/month throughout on PlexusDx month-to-month, while the same patient on Emerge would see their monthly bill rise from $224 to $289 (existing-patient tier). Over 12 months at 15 mg, both platforms cost $3,468; PlexusDx reaches that rate immediately, Emerge only at the top tier.

The six-month PlexusDx commitment ($249/month, $2,988/year) matches Emerge's 7.5 mg rate but covers any dose, which may appeal to patients uncertain about their peak dose.

Regulatory and compounding disclosures

Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient.

PlexusDx works with licensed 503A compounding pharmacies.

Both Emerge Weight Loss and PlexusDx dispense compounded tirzepatide, not Mounjaro or Zepbound. Compounded tirzepatide is not the same as branded tirzepatide and has not undergone FDA premarket review.

Choose Emerge Weight Loss if…

• You expect to remain at a starter or mid-range dose (2.5 mg through 10 mg) for the majority of your treatment, minimizing cumulative cost.
• You prefer month-to-month flexibility without committing to three- or six-month billing cycles.
• You are comfortable with monthly price increases as your clinician titrates your dose upward.
• You are interested in the oral dissolving tablet formulation at $149/month or the $148/month maintenance program after reaching goal weight.

Choose PlexusDx if…

• You value predictable monthly billing throughout dose escalation and do not want your cost to rise as your dose increases.
• You expect to titrate to higher doses (12.5 mg or 15 mg) and want a locked-in rate from the start.
• You are willing to commit to three or six months to access rates ($269 or $249) that match or beat Emerge's mid-range tiers at any dose.
• You prefer oral capsules over dissolving tablets, or you are considering the $129/month microdose GLP-1 injection for maintenance.

Service quality and patient experience

PlexusDx holds a 4.3-star rating on Trustpilot, with 79 percent of reviews at five stars and 83 percent at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). The research packet for this article did not include verified review data for Emerge Weight Loss, so no comparative service-quality analysis is possible. Prospective patients should confirm current review ratings, response times, and customer-support availability directly with Emerge before enrollment.

Methodology and freshness

Emerge Weight Loss pricing was captured September 4, 2026 from emergeweight.com/pricing. PlexusDx pricing was captured September 13, 2026 from plexusdx.com/products/tirzepatide-injection and the PlexusDx pricing database. All 12-month cost totals and annual savings figures are our calculation (monthly rate × 12 or summed month-by-month where dose changes). No promotional, introductory, or first-month pricing was identified for Emerge; all figures represent standard ongoing monthly rates. Dose restrictions (12.5 mg and 15 mg existing-patient tiers) are stated as published on Emerge's pricing page. We recommend confirming current pricing, dose availability, and eligibility criteria at checkout before enrollment.

Frequently Asked Questions

Does Emerge Weight Loss charge extra fees for doctor visits or shipping?

No. Emerge advertises no signup fee, no doctor fee, no shipping fee, and no membership fee for standard tirzepatide plans. The monthly price listed for each dose tier is all-inclusive, covering medication, provider access, and shipping (emergeweight.com/pricing, captured September 4, 2026).

Can new patients start at 12.5 mg or 15 mg on Emerge Weight Loss?

No. The 12.5 mg and 15 mg dose tiers are available to existing patients only. New enrollees begin at lower doses (typically 2.5 mg or 5 mg) and titrate upward under clinician supervision. This restriction was stated on Emerge's pricing page captured September 4, 2026.

How does PlexusDx pricing compare if I expect to reach 15 mg tirzepatide?

At 15 mg, Emerge charges $289/month (existing patients only), identical to PlexusDx month-to-month at any dose. Over 12 months both cost $3,468. PlexusDx offers the same $289 rate to new patients from day one at any dose, while Emerge reserves the 15 mg tier for existing patients who have titrated up from lower doses.

What is the difference between Emerge's oral dissolving tablet and PlexusDx oral capsules?

Emerge offers an oral dissolving tablet (ODT) formulation of compounded tirzepatide at $149/month; PlexusDx offers tirzepatide oral capsules at $349/month month-to-month, $299/month on a three-month commitment, and $279/month on a six-month commitment. Both are compounded formulations administered orally, but the delivery mechanism (dissolving tablet vs swallowed capsule) and pricing differ substantially.

Does either platform require a contract or minimum commitment for tirzepatide injections?

Emerge Weight Loss operates month-to-month with no stated minimum commitment for standard tirzepatide injection plans. PlexusDx offers month-to-month billing at $289/month or discounted rates tied to three-month ($269/month) or six-month ($249/month) commitments; patients who prefer no commitment can select the month-to-month option.

Sources

• Emerge Weight Loss pricing page, emergeweight.com/pricing, accessed September 4, 2026.
• PlexusDx tirzepatide injection product page, plexusdx.com/products/tirzepatide-injection, accessed September 13, 2026.
• PlexusDx Trustpilot profile, trustpilot.com/review/plexusdx.com, accessed September 9, 2026.
• PlexusDx pricing database, accessed September 13, 2026.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.